Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
巴姆拉尼维单抗联合依特塞维单抗治疗轻度或中度新冠肺炎
期刊:New England Journal of Medicine
影响因子:78.5
doi:10.1056/NEJMoa2102685
Dougan, Michael; Nirula, Ajay; Azizad, Masoud; Mocherla, Bharat; Gottlieb, Robert L; Chen, Peter; Hebert, Corey; Perry, Russell; Boscia, Joseph; Heller, Barry; Morris, Jason; Crystal, Chad; Igbinadolor, Awawu; Huhn, Gregory; Cardona, Jose; Shawa, Imad; Kumar, Princy; Adams, Andrew C; Van Naarden, Jacob; Custer, Kenneth L; Durante, Michael; Oakley, Gerard; Schade, Andrew E; Holzer, Timothy R; Ebert, Philip J; Higgs, Richard E; Kallewaard, Nicole L; Sabo, Janelle; Patel, Dipak R; Dabora, Matan C; Klekotka, Paul; Shen, Lei; Skovronsky, Daniel M